Biopharma Daily Stock Updates - 03/30/21

$XBI $130.11 +1%

Pipeline Updates

$EQ +10% Ph 1b data. source


$BSGM +6% Awarded US patent. source


$IMAB +6% IND approved for solid tumors. source


$KRYS +5% Complete ph 3 enrollment. source


$FMTX -2% New ph 1 data & ph 2/3 initiation. source


$AMRN +4% EU approval of Vazkepa. source


$CARA +4% EMA accepted MAA for review, decision expected Q2 2022. source


Finance Updates

$PRQR -12% Offering. source


$OVID +2% closed agreement with Takeda for TAK-935. source

0 comments